* Received letter dated May 31, 2016 from Capital Royalty
Partners II L.P and Capital Royalty Partners II Parallel Fund A
L.P. (CRG)
The post BRIEF-Navidea Biopharma says continuing to explore alternative financing to refinance some debt appeared first on NASDAQ.